Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, OrthoPediatrics Corp reported revenue of $236M, up 15.4% year over year. Operating margin was -16.6% and net margin -16.8%, on a free-cash-flow margin of -6.8% with capital expenditure at 4.7% of revenue. Every figure is computed directly from KIDS's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $236M | -16.6% | -16.8% |
| FY2024 | $205M | -17.1% | -18.5% |
| FY2023 | $149M | -18.0% | -14.1% |
| FY2022 | $122M | -20.8% | 1.0% |
| FY2021 | $98M | -18.4% | -16.6% |
How does KIDS compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Related in the same sector: A · ACHR · AEHR · AERG · AEVA · AIRI
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.